Correlation Between AbbVie and AstraZeneca PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AbbVie and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and AstraZeneca PLC, you can compare the effects of market volatilities on AbbVie and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and AstraZeneca PLC.

Diversification Opportunities for AbbVie and AstraZeneca PLC

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between AbbVie and AstraZeneca is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and AstraZeneca PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC has no effect on the direction of AbbVie i.e., AbbVie and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between AbbVie and AstraZeneca PLC

Assuming the 90 days trading horizon AbbVie Inc is expected to generate 1.25 times more return on investment than AstraZeneca PLC. However, AbbVie is 1.25 times more volatile than AstraZeneca PLC. It trades about 0.05 of its potential returns per unit of risk. AstraZeneca PLC is currently generating about 0.04 per unit of risk. If you would invest  347,700  in AbbVie Inc on September 19, 2024 and sell it today you would earn a total of  5,807  from holding AbbVie Inc or generate 1.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

AbbVie Inc  vs.  AstraZeneca PLC

 Performance 
       Timeline  
AbbVie Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, AbbVie is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
AstraZeneca PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

AbbVie and AstraZeneca PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AbbVie and AstraZeneca PLC

The main advantage of trading using opposite AbbVie and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.
The idea behind AbbVie Inc and AstraZeneca PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios